ArticleOsteoporosis and sarcopenia2019

Safety and efficacy in actual clinical practice of once-weekly subcutaneous teriparatide for osteoporosis patients with a high fracture risk.

Emiko Ifuku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.